Patent · US Expired

Oral fludara of high-purity formulation with quick release of active ingredient

US7148207B2 · kind B2 · utility

0Cited by

9References

12Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Wolfgang Heil · Berlin, DE
Ulf Tistam · Wezembeek-Oppem, BE
Ralph Lipp · Berlin, DE
Johannes Tack · Berlin, DE

Key dates

Filing date	Dec 20, 2002
Grant date	Dec 12, 2006
Priority date	—
Expiry date	Dec 20, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.